Pacb stock. 65 for 2025, with the lowest EPS forecast at -$1.

Pacb stock Jul 16, 2024 · PacBio (PACB) stock jumps as management schedules its Q2 2024 earnings release and Ark Investment Management buys company shares. 4% in the afternoon session after the company announced it had joined the 1000 Genomes Long Read Sequencing Find the latest Pacific Biosciences of California, Inc. Here’s what investors should know. The company expects its Q1 revenue to be $36. Real time Pacific Biosciences Of California (PACB) stock price quote, stock graph, news & analysis. The company expects its Q1 Jul 23, 2025 · Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7. See recent price targets, upgrades/downgrades, buy/sell/hold ratings, and more. Approximately 1,365,774 shares traded hands during trading, a decline of 85% from the average daily volume of 9,219,410 shares. 44, representing a -1. View and compare PACB on Yahoo Finance. raised the price target on the stock while Pacific Biosciences of California, Inc. In this article, we are going to take a look at where Pacific Biosciences of California, Inc. Find out all the key statistics for Pacific Biosciences of California, Inc. 95 million, and the earnings are Feb 13, 2025 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 0% and 0. PACB, popularly known as PacBio, has been gaining from its continued product development. View (PACB) real-time stock price, chart, news, analysis, analyst reviews and more. 9% move from the previous day. 2% decrease in average from the prior price target of the each prediction. Feb 13, 2025 · PacBio (PACB) reported Q4 2024 financial results with revenue of $39. Feb 14, 2025 · Despite strong Service and other revenues, PacBio reports soft fourth-quarter 2024 results partly due to lower Revio system shipments. Key Developments Impacting PACB Agreement finalized allowing PACB to expand 2 days ago · $PACB stock has now risen 13% today, according to our price data from Polygon. 1% in the morning session after the company reported better-than-expected second-quarter 2025 financial results Pacific Biosciences of California (NASDAQ:PACB) stock price jumped 22% on Wednesday after the company laid down its preliminary Q1 numbers. historical stock charts and prices, analyst ratings, financials, and today’s real-time PACB stock price. New launches and clinical focus set the stage for market growth in 2025. Dec 11, 2024 · We recently published a list of 10 Worst ARK Stocks To Buy According to Short Sellers. 16 million, and the earnings are Find the latest Pacific Biosciences of California, Inc. View daily, weekly or monthly format back to when Pacific Biosciences of California, Inc. 00 from 18 Wall St analysts. May 20, 2025 · Pacific Biosciences (PACB) or PacBio, develops and sells advanced sequencing solutions for genetic analysis. Nov 8, 2025 · Get the latest Pacific Biosciences (PACB) stock analysis report: in-depth insights, analyst ratings, financials, and historical performance. 60, and the highest EPS forecast at -$0. The consensus estimate for Q3 2024 revenue is $41. 01 per share), compared to a loss of $82. 3 days ago · Live Update At 11:32:26 EST: On Friday, November 21, 2025 Pacific Biosciences of California Inc. Find the latest Pacific Biosciences of California, Inc. What Happened: Pacific Biosciences of California Inc. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. 65 for 2025, with the lowest EPS forecast at -$1. 02% , ranging from a day low of $1. 94, as the company faces a tumultuous market environment. First quarter results: Revenue of $38. (PACB) stock, including real-time price, chart, key statistics, news, and more. Get the latest Pacific Biosciences of California, Inc. (PACB) stock price, market cap, P/E ratio, revenue, earnings call summary, income statement, key executives, and financial performance on NASDAQ. (PACB) stock, including valuation metrics, financial numbers, share information and more. 9 Jan 14, 2025 · MENLO PARK, Calif. ’s stock has taken a hit amid investor concerns following a disappointing quarterly earnings report and fears of increased competition in the gene sequencing market. 85 to 2. 13, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Nov 12, 2024 · Rick Munarriz is a contributing Motley Fool stock analyst and long-time contributor to the company’s free offerings and premium investing services, including Rule Breakers and Supernova. 90 with a stock forecast range of $1. Oct 16, 2024 · In the latest trading session, Pacific Biosciences of California (PACB) closed at $2. Stocks, ETFs, mutual funds, and bonds are covered. Nov 10, 2025 · View Pacific Biosciences of California, Inc. See why I think maintaining a sell recommendation on PACB is prudent. Nov 12, 2024 · Pacific Biosciences of California stock surged 50% despite a revenue decline & low margins. Discover Pacific Biosciences of California's earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. Nov 11, 2025 · Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2. 65. View the latest Pacific Biosciences of California Inc. Read Next: FDA Approves Bristol Myers’ Opdivo Plus Yervoy Combo For Untreated Colorectal Cancer Patients (NASDAQ: PACB) Pacific Biosciences Of California's current Earnings Per Share (EPS) is -$1. 235. ’s stocks have been trading down by -8. 22. May 23, 2025 · PACB expands reach in China through Haorui Gene partnership, bringing HiFi sequencing to new clinical labs and boosting precision medicine access nationwide. Throughout the last trading session, the stock experienced a fluctuation of 22. 55 for 2026, with the lowest EPS forecast at -$0. (PACB Quick Quote PACB - Free Report) , popularly known as PacBio, delivered an adjusted loss per share of 20 cents in fourth-quarter 2024, narrower than 3 days ago · Should I buy Pacific Biosciences Of California (PACB)? Use the Zacks Rank and Style Scores to find out is PACB is right for your portfolio. Jan 8, 2025 · Track PACB Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. , May 9, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2024. chart to track its stock's price action. 145, reflecting a 14. (PACB) stock discussion in Yahoo Finance's forum. This move comes without a fresh catalyst, as the stock does not have any recent press releases or materials influencing its performance today. The quarter saw instrument revenue of $15. 64, a current ratio of 9. Common Stock (PACB) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Should You Buy or Sell Pacific Biosciences of California Stock? Get The Latest PACB Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. PACB stock price ended at $ 2. 16 and a 12-month high of $6. Dec 12, 2024 · PACB continues to deliver growth from its unique technologies amid business seasonality concerns. Discover real-time Pacific Biosciences of California, Inc. Feb 26, 2025 · PACB stock opened at $1. 3 million, including 23 Revio® and 7 Vega™ systems, while consumables revenue remained flat at $18. Read more here. Mar 31, 2025 · PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. PACB recently announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Pacific Biosciences (PACB) Stock forecast & analyst price target predictions based on 5 analysts offering 12-months price targets for PACB in the last 3 months. (PACB) stock, starting from its first trading day. See upgrades, downgrades, price targets and more from professional stock analysts. (NASDAQ:PACB) investors who have held the stock for three years as it declined a whopping 86%. 3 days ago · Check if PACB Stock has a Buy or Sell Evaluation. Its Apr 30, 2021 · PACB : Pacific Biosciences of California stock forecast by Wall Street Analysts The average Pacific Biosciences of California stock forecast from last 6 month is $1. 7650. The optimism, led by decent fourth-quarter results, is expected to Feb 13, 2025 · Genomics company Pacific Biosciences of California (NASDAQ:PACB) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 32. company facts, information and financial ratios from MarketWatch. 61 by PACB 's total outstanding shares of 301,907,431. Pacific Biosciences of California Inc. View real-time PACB stock price and news, along with industry-best analysis. 3 days ago · Find out the current price target and stock forecast for Pacific Biosciences of California (PACB) Find the latest Pacific Biosciences of California, Inc. 2 million, marking a 33% decrease from $58. Feb 1, 2025 · So consider, for a moment, the misfortune of Pacific Biosciences of California, Inc. 81 and last traded at $1. 2 days ago · Get real-time Pacific Biosciences (PACB) stock price, charts, news, and analyst ratings on Benzinga. Do the numbers hold clues to what lies ahead for the stock? Find the latest Pacific Biosciences of Californ PACB analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Aug 8, 2025 · Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 7. 3 days ago · When is Pacific Biosciences of California's next earnings announcement? View the latest PACB earnings date, analysts forecasts, earnings history, and conference call transcripts. , Jan. The optimism, led by decent fourth-quarter results, is expected to Mar 20, 2025 · Pacific Biosciences of California, Inc. 37% change from its previous close. (PACB) stock news and headlines to help you in your trading and investing decisions. Stay ahead Jul 24, 2017 · View live Pacific Biosciences of California, Inc. 59. Feb 8, 2024 · PacBio's financials for 2023 show significant growth, with revenue more than doubling in Q4 and a 56% increase in annual revenue. com: Providing the education and guidance needed to build and manage investment wealth. (PACB) stock. Buy PACB stock at Webull. 4 days ago · A high-level overview of Pacific Biosciences of California, Inc. 5 days ago · Detailed statistics for Pacific Biosciences of California, Inc. May 22, 2025 · Pacific Biosciences (NASDAQ: PACB) of California, Inc. 49 Nov 7, 2025 · Pacific Biosciences of California Inc. 2 days ago · Stock forecasts and analyst price target predictions for Pacific Biosciences of California, Inc. 4% year on year to $39. Click here to see why PACB stock is a Sell. Interactive Chart for Pacific Biosciences of California, Inc. Nov 7, 2024 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 15% and 4. Get latest news and stock predictions. (PACB) stock, with detailed revenue and earnings estimates. Dec 5, 2024 · Ark Invest CEO Cathie Wood is doubling down on genomics. Feb 12, 2025 · Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. stock [NASDAQ: PACB] is trending up by 11. Latest and historical data Chart of PACB price Sep 15, 2025 · Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 2% in the pre market session after the stock extended its positive momentum as the company partnered with DKSH and Jul 17, 2025 · Pacific Biosciences of California (PACB) reached $1. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. stock information by Barron's. Looking to buy PACB Stock? Get the latest PACB quote, news, earnings, forecast, price targets, and market insights. In my last analysis, I stated that the convertible debt the company issued would likely drag the stock. Jan 7, 2025 · Cathie Wood added to her stakes in Amazon, GitLab, and PacBio on Monday. Nov 10, 2025 · View real-time stock prices and stock quotes for a full financial overview. Quick Financial Overview Looking closer at the recent numbers, the picture is a mix of gains and hurdles. Shareholders of PacBio would probably like to forget the past six months even happened. 8% in the afternoon session after an analyst at Stephens & Co. 2% and now trades at $1. 50-$3. Other Robinhood Financial fees may apply, check rbnhd. On average, analysts forecast that PACB's EPS will be -$1. These devices allow for a reduction in the amount of DNA required to sequence the genome. Pacific Biosciences Of California 's market cap is calculated by multiplying PACB 's current stock price of $1. Nov 13, 2025 · The latest Pacific Biosciences of California stock prices, stock quotes, news, and PACB history to help you invest and trade smarter. 17%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below. 8317 to a day high of 2. 74 4 days ago · Shares of Pacific Biosciences of California, Inc. 09. (PACB), analyze all the data with a huge range of indicators. (PACB) stock has hit a 52-week low, dropping to $0. Add a live free portfolio. There has been approximately $36,710,300 of trading volume. PACB stock quote prices, financial information, real-time forecasts, and company news from CNN. The company reported a GAAP net income of $3. There has been approx Mar 20, 2025 · Pacific Biosciences of California, Inc. The stock had previously closed at $1. Feb 4, 2025 · The latest trading day saw Pacific Biosciences of California (PACB) settling at $1. 90, and the highest EPS forecast at -$0. However At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Feb 12, 2025 · Genomics company Pacific Biosciences of California (NASDAQ:PACB) will be announcing earnings results tomorrow after market hours. In the year-to-date period, PACB’s shares have lost 38. 3 days ago · Pacific Biosciences of California, Inc. Share your opinion and gain insight from other stock traders and investors. All 31 Pacific Biosciences of California Inc (PACB) purchases and sells made by Cathie Wood (ARK Invest). (PACB) is showing a notable uptick, currently priced at $2. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ. The company has a quick ratio of 8. PACB and Intus Bio, a leader in microbiome research and discovery, recently unveiled GutID, the first commercial human gut health test powered by Intus Bio Feb 13, 2025 · MENLO PARK, Calif. The stock traded as high as $1. Aug 20, 2025 · Get the latest Pacific Biosciences of California, Inc. Jun 2, 2025 · Pacific Biosciences of California faces steep stock decline and financial challenges. 8% compared PACB Analyst Forecast & Price Prediction Get the latest PACB stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis Sep 8, 2025 · Pacific Biosciences stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. (PACB). co/fees for details. Amazon has been riding the bullish momentum as a "Magnificent Seven" stock, but net sales growth is unlikely to top 12% for Apr 9, 2025 · Price Action: PACB stock is up 8. 56 on Tuesday. This was partly due to its softer quarterly results and Pacific Biosciences of California Inc. 75% at $1. Find market predictions, PACB financials and market news. The stock dropped 35. 06, marking a -1. 2 days ago · A detailed overview of Pacific Biosciences of California, Inc. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Learn why top analysts are making this stock forecast for Pacific Biosciences of California at MarketBeat. 39 at the closing of the latest trading day, reflecting a -6. Do the numbers hold clues to what lies ahead for the stock? Mar 31, 2024 · MENLO PARK, Calif. Long-term PACB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050 Based on our analysis about Pacific Biosciences Of California Inc financial reports and earnings history, Pacific Biosciences Of California Inc (PACB) stock could reach $4. , Feb. Pacific Biosciences of California (NASDAQ:PACB) ranks among the best CRISPR stocks to buy. 60%, respectively, for the quarter ended September 2024. 09% The Pacific Biosciences of California Inc stock price increased by 18. Its non-GAAP Track Pacific Biosciences (PACB) stock price, view market trends and access key financial insights. Jan 13, 2025 · PACB and Intus Bio collaborate to launch GutID, the first commercial human gut health test. Speaking on its strategic developments and challenges, Pacific Biosciences of California (NASDAQ:PACB Nov 6, 2024 · Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q3 2024 earnings on Nov 7, 2024. stock was issued. (NASDAQ:PACB - Get Free Report) rose 7% during trading on Wednesday . (PACB), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. 91 percent. 69. May 12, 2025 · PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve View PACB Stock Real Time Quote, Pacific Biosciences of California, Inc stock price with interactive chart, get the latest alerts for Pacific Biosciences of California, Inc, with indicator levels, dividend and earnings details. Start investing on Public. Nov 9, 2025 · PacBio (PACB) has a price target of $1. 71% change compared to its last close. If you are looking for an AI stock that is more promising than PACB and that has 10,000% upside potential, check out our report about this cheapest AI stock. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced preliminary unaudited revenue for Oct 27, 2010 · A complete stock price history for Pacific Biosciences of California, Inc. 8 million compared with $38. Discover historical prices for PACB stock on Yahoo Finance. 22 million. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. How much will Pacific Biosciences of California Shares cost tomorrow? Feb 14, 2025 · $PACB stock has now risen 25% today, according to our price data from Polygon. 0877 by 2040 and $5. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live stock price. 5% AAII. Feb 14, 2025 · Pacific Biosciences of California, Inc. Pacific Biosciences of California has a 12-month low of $1. 8 million. See Pacific Biosciences of California, Inc. analyst estimates, including PACB earnings per share estimates and analyst recommendations. Access forecasts, historical data, and expert insights to inform your investment decisions. Learn how to buy Pacific Biosciences stock securely on Kraken. Find out the direct holders, institutional holders and mutual fund holders for Pacific Biosciences of California, Inc. Jul 23, 2025 · I have written about Pacific Biosciences ("PacBio") (PACB) multiple times before. 05 by 2050. Find the latest Pacific Biosciences of California, Inc. Likely Trend of PACB Stock Following the News Following the announcement, shares of the company closed flat at $1. com. Pacific Biosciences (PACB) offers advanced long-read sequencing solutions that deliver precision genomic insights for scientific and clinical research. 25. 51, and this show a -14. PACB - Pacific Biosciences of California Inc - Stock screener for investors and traders, financial visualizations. Jan 23, 2025 · Pacific Biosciences of California Inc. chart, PACB stock price in real-time and PACB historical prices. (PACB) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Includes open, high, low, close and volume. 6 million ($0. However, geographically, revenues declined in the Americas, Asia-Pacific region and EMEA, which seems concerning. Pacific Biosciences (PACB) Jumps 6. (NASDAQ: PACB), known as PacBio, is biotech’s new kid on the block. The consensus estimate for Q4 2024 revenue is $40. 4 million in the prior year. Webull offers PACB Ent Holdg (PACB) historical stock prices, in-depth market analysis, NASDAQ: PACB real-time stock quote data, in-depth charts, free PACB options chain data, and a fully built financial calendar to help you invest smart. Aug 7, 2025 · Genomics company Pacific Biosciences of California (NASDAQ:PACB) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 10. 22 on Friday, after rising 18. Pacific Biosciences (PACB) Stock forecast & analyst price target predictions based on 5 analysts offering 12-months price targets for PACB in the last 3 months. 09% on the last trading day (21 Nov 2025), rising from 1. Apr 9, 2025 · Pacific Biosciences of California (PACB) stock price jumped 9% on Wednesday after the company laid down its preliminary Q1 numbers. Find out why PACB stock is a Buy. 31 at the last check Wednesday. 06%, respectively, for the quarter ended December 2024. 5 days ago · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. 8% year on year to $39. On average, analysts forecast that PACB's EPS will be -$0. Pacific Biosciences of California, Inc. PACB Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Pacific Biosciences of California Jan 15, 2025 · PacBio announces positive study results for HiFi long-read sequencing technology in identifying genetic causes of rare diseases. 77 million. The company's 4 days ago · Live Pacific Biosciences of California, Inc. Fourth quarter results Revenue of Pacific Biosciences of California Inc. 3213 by 2030, $5. 12 on Friday. Nov 6, 2025 · Pacific Biosciences of California Stock Price Predictions for 2025, 2026, 2027 using artificial intelligence. Get Pacific Biosciences news, earnings, and stock analysis — all in one place at TipRanks. You can buy and sell Pacific Biosciences (PACB) and other stocks, ETFs, and their options commission-free on Robinhood with real-time quotes, market data, and relevant news. Jan 14, 2025 · PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. With a market capitalization of . Complete Pacific Biosciences of California Inc. View the latest analyst forecasts for Pacific Biosciences of California, Inc. 1% increase amid normal trading. 3 days ago · PACB's current price target is $2. 3 days ago · What's going on at Pacific Biosciences of California (NASDAQ:PACB)? Read today's PACB news from trusted media outlets at MarketBeat. (NASDAQ:PACB See Pacific Biosciences of California, Inc. Nov 8, 2024 · PACB saw an uptick in Product, Service and other, and Consumable revenues. On Thursday, Pacific Biosciences of California Inc. Recently, the company reported Nov 4, 2025 · Current and historical analyst ratings for PACB (PACB) stock. 00. Updated November 2025 for smarter investing decisions. Clinical Research Spotlight Enhances Market Sentiment The recent performance surge appears to be Jan 15, 2025 · PacBio reports dismal preliminary fourth-quarter 2024 results, caused by lower instrument. 9M, higher Jan 10, 2025 · PacBio delivers the first Vega systems to Berry Genomics to develop and optimize its targeted assays to support screening programs in China and other markets. kisrcjoy obrciq yqpxao ayz wyxgqn mzf dpnofr esdmvo dhuyk rwduivr zvmc ggf ugmiuq kfmjj jybqm